PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alpine Immune Sciences, Inc. (ALPN)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US02083G1004

CUSIP

02083G100

Sector

Healthcare

IPO Date

Jun 17, 2015

Highlights

Market Cap

$4.46B

EPS (TTM)

-$0.64

Total Revenue (TTM)

$37.89M

Gross Profit (TTM)

$37.59M

EBITDA (TTM)

-$20.85M

Year Range

$16.77 - $64.97

Target Price

$62.00

Short %

8.27%

Short Ratio

0.96

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ALPN vs. AAOI ALPN vs. RXST ALPN vs. USLM ALPN vs. ELF ALPN vs. MSTR
Popular comparisons:
ALPN vs. AAOI ALPN vs. RXST ALPN vs. USLM ALPN vs. ELF ALPN vs. MSTR

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alpine Immune Sciences, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


ALPN (Alpine Immune Sciences, Inc.)
Benchmark (^GSPC)

Returns By Period


ALPN

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y (annualized)

N/A

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

27.68%

1M

2.72%

6M

13.90%

1Y

32.81%

5Y (annualized)

14.15%

10Y (annualized)

11.47%

Monthly Returns

The table below presents the monthly returns of ALPN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202439.61%32.36%12.55%62.94%240.87%
202314.29%-5.12%-3.14%-2.98%32.98%3.21%21.98%-1.52%-7.29%-10.57%51.37%22.97%159.32%
2022-38.63%-3.06%8.86%2.56%1.09%-8.49%-6.58%-5.53%-4.13%-17.92%6.26%17.04%-46.93%
20212.14%-8.94%-9.56%25.19%-19.67%-15.57%-1.78%7.58%12.20%18.56%-14.39%27.89%9.92%
2020-21.87%4.00%-7.69%2.43%25.42%162.43%18.43%-29.04%7.72%-14.68%30.13%29.10%228.12%
201973.91%5.65%1.45%-7.29%-22.33%-14.78%0.71%-1.53%-5.15%-15.66%-9.28%26.73%4.35%
2018-0.98%-20.74%-8.99%-2.75%15.42%-15.70%-7.86%-3.66%-5.80%-26.86%3.67%-23.33%-67.14%
2017-1.79%24.09%6.96%-22.60%1.77%4.78%-8.82%-0.46%32.57%-13.53%4.79%6.57%25.00%
2016-39.41%-3.41%-7.95%1.44%17.97%-7.82%1.74%36.54%27.23%-27.06%-63.41%3.23%-71.06%
20151.54%12.01%-14.32%-10.80%-38.16%3.49%-6.75%-48.12%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALPN is 53, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALPN is 5353
Overall Rank
The Sharpe Ratio Rank of ALPN is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of ALPN is 7070
Sortino Ratio Rank
The Omega Ratio Rank of ALPN is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ALPN is 3131
Calmar Ratio Rank
The Martin Ratio Rank of ALPN is 3434
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alpine Immune Sciences, Inc. (ALPN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
ALPN
^GSPC

There is not enough data available to calculate the Sharpe ratio for Alpine Immune Sciences, Inc.. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
ALPN (Alpine Immune Sciences, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Alpine Immune Sciences, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


ALPN (Alpine Immune Sciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alpine Immune Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alpine Immune Sciences, Inc. was 97.33%, occurring on Mar 17, 2020. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-97.33%Aug 24, 20151149Mar 17, 2020
-12.05%Jul 20, 201511Aug 3, 201514Aug 21, 201525
-1.43%Jul 6, 20153Jul 8, 20152Jul 10, 20155
-1.14%Jul 13, 20151Jul 13, 20151Jul 14, 20152
-1.14%Jun 18, 20151Jun 18, 20156Jun 26, 20157

Volatility

Volatility Chart

The current Alpine Immune Sciences, Inc. volatility is 0.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


ALPN (Alpine Immune Sciences, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alpine Immune Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Alpine Immune Sciences, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab